The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Does dose modification affect efficacy of first-line pazopanib in metastatic renal cell carcinoma?
 
Paolo Grassi
No Relationships to Disclose
 
Giuseppe Procopio
Honoraria - Janssen; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb
 
Raffaele Ratta
No Relationships to Disclose
 
Luca Porcu
No Relationships to Disclose
 
Antonia Martinetti
No Relationships to Disclose
 
Alessia Mennitto
No Relationships to Disclose
 
Elena Verzoni
Honoraria - Novartis
Consulting or Advisory Role - Janssen; Pfizer